Cystatin C as a biomarker of chronic kidney disease: latest developments
Introduction Chronic kidney disease (CKD) is common, occurring in over 10% of individuals globally, and is increasing in prevalence. The limitations of traditional biomarkers of renal dysfunction, such as serum creatinine, have been well demonstrated in the literature. Therefore, augmenting clinical...
Збережено в:
| Автори: | , , |
|---|---|
| Формат: | Revisão |
| Мова: | Англійська |
| Опубліковано: |
2020
|
| Онлайн доступ: | https://doi.org/10.1080/14737159.2020.1768849 |
| Теги: |
Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|